Inclusion Criteria:
  1. Colon or rectal cancer diagnosed by endoscopic biopsy histopathology;
  2. Complete sample information, including sample number, gender, age and clinical molecular diagnostic information, etc.;
  3. Sufficient surgical tissue samples are available for testing;
  4. untreated colon or rectal cancer patients;
  5. Patient able to understand and sign written informed consent
  6. No evidence of distant metastasis (M0)
Exclusion Criteria:
  1. Previously treated CRC, including cytotoxic drug therapy, targeted drug therapy, etc.;
  2. Other malignant tumors;
  3. Pregnant women;
  4. Hereditary colorectal cancer linked to familial colonic polyposis or Lynch syndrome